Posts Tagged ‘cancer’
HER2-targeting antibody-drug improves progression-free survival for women with deadly form of metastatic breast cancer
Treating women with HER2 positive metastatic breast cancer with the HER2-targeting antibody-drug conjugate significantly improves …
Read Full ArticleGut microbiome might be an indicator of colorectal cancer risk
Study reports that the increased presence of certain bacteria in a gut microbiome indicates a greater likelihood that colon polyps will become cancerous. …
Read Full ArticleImproving chronic leukemia therapy with targeted treatment approaches
Targeted combination therapy could be a novel treatment approach for chronic leukemias. …
Read Full ArticleUveal melanoma discovery points to new treatment possibilities
Study reveals in detail how the most common primary eye cancer in adults, uveal melanoma, can progress from a slow-growing state to a lethal metastasizing state. …
Read Full ArticleResearchers find immune cells that guard frequent site of melanoma spread
A newly identified population of long-lived T cells in lymph nodes provides protection against melanoma spread. …
Read Full ArticleBreast cancer ‘ecotypes’ present new path to personalized treatment
A new approach for classifying breast cancer subtypes based on their cell profile could help personalize treatments. …
Read Full ArticleEngineers grow pancreatic organoids that mimic the real thing
Researchers have developed a new way to grow pancreatic organoids using either healthy or cancerous pancreatic cells. …
Read Full ArticleAntitumor activity of tumor-associated eosinophils
A new study found that eosinophils – a type of white blood cells – are recruited to the battle against cancer metastases in the lungs. …
Read Full ArticleExercise relieves tumor-associated anemia
Researchers used a mouse model to pinpoint the underlying causes of tumor-associated anemia, establishing the beneficial effects of exercise in ameliorating this condition. …
Read Full ArticleThird of cancer drugs without proven clinical benefit continue to be recommended for patients
One-third of cancer drugs that received accelerated FDA approval continue to be recommended in clinical guidelines after clinical trials fail to show improvement on their primary endpoints. …
Read Full Article